# Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial

> **NCT02799823** · NA · TERMINATED · sponsor: **HLT Inc.** · enrollment: 11 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** HLT Transcatheter Aortic Valve System

## Key facts

- **NCT ID:** NCT02799823
- **Lead sponsor:** HLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-27
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** HLT Business Decision
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799823, "Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02799823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*